Anti-VEGF.herapy Avastin, Lucentis, Eylea Anti-VEGF therapy involves the injection of the medication into the back of your eye. Proliferative Retinopathy and Vitreous haemorrhage Proliferative retinopathy refers to the changes that occur when new, abnormal blood vessels begin to grow on the surface of your retina. It is the leading cause of blindness in North America. Patients on certain medications should have more frequent eye exams. Angiogenesis is the hallmark precursor that may result in blindness or severe vision loss, particularly if the macula becomes affected. 1 Retinopathy may more rarely be due to ciliopathic genetic disorders, such as Alström syndrome or Bardet–Biedl syndrome . 3 retinopathies is diagnosed by an ophthalmologist during eye examination. Because diabetic retinopathy often lacks early symptoms, people with diabetes should get a comprehensive dilated eye exam at least once a year. But if retinopathy is diagnosed early, blindness can be prevented. A comprehensive dilated eye exam allows the doctor to check the retina for: Leaking blood vessels or warning signs of leaky blood vessels, such as fatty deposits If DBE or severe diabetic retinopathy is suspected, a fluoresce in angiogram may be used to look for damaged or leaky blood vessels.
Controlling blood sugar levels in diabetes is critical in delaying the onset of diabetic retinopathy. The same instruments used during vitrectomy also may be used to remove scar tissue or to repair a detached retina. The FDA has approved Lucentis for macular enema and additional treatment options include Avastin and Eylea.